Shalby Hospitals

Q2 FY24 Results Review

Decent results
Total Revenue at Rs. 2,43.4 Cr grew by 17.5% YoY
EBITDA at Rs. 58.1 Cr grew by 37.1% YoY
EBITDA Margin at 23.9% in Q2 FY24

Consolidated Performance Highlights:
 Consolidated Revenues of Rs. 2,434 million, growth of 17.5% y-o-y and 1.4% q-o-q
 Consolidated EBITDA of Rs. 581 million, growth of 37.1% y-o-y and 21.9% q-o-q
 Consolidated EBITDA margin at 23.9% v/s 20.5% in Q2 FY23 and 19.9% in Q1 FY24
 Consolidated PBT of Rs. 426 million, growth of 48.6% y-o-y and 29.3% q-o-q
 Consolidated Basic EPS of Rs. 2.57 during the quarter, growth of 32% q-o-q
Standalone Performance Highlights:
 Standalone Revenues of Rs 2,230 million, growth of 22.0% y-o-y and 3.1% q-o-q
 Standalone EBITDA of Rs. 575 million, growth of 31.6% y-o-y and 15.6% q-o-q
 Standalone EBITDA margin of 25.8% in Q2 FY24 v/s 24% in Q2 FY23 and 23% in Q1 FY24
 Standalone PBT of Rs. 473 million, growth of 41.1% y-o-y and 18.3% q-o-q
 Standalone ROCE (annualized) at 23% v/s 16% in FY23
Hospital Operational Highlights:
 In patient count (incl. Day Care) of 22.652, growth of 21.6% y-o-y
 Total Surgery count of 7,771, growth of 14.2% y-o-y
 Occupancy rate at 54% in Q2 FY24 v/s 49% in Q2 FY23
 ARPOB during the quarter was 36,136, growth of 8.1% y-o-y

Press release Q2 FY 24 (https://www.bseindia.com/xml-data/corpfiling/AttachLive/49a6e7e9-3b9b-4cf5-ba05-e36c7790f5d4.pdf)